Acrospire Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-442
Closed -$2K 2143
2017
Q1
$2K Buy
+442
New +$2K ﹤0.01% 2100